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j ourna l homepage: www.e lsev ie r .com/ locate /bbad isEditorialThe role of post-translational protein modifications on heart and
vascular metabolismThe emergence ofmetabolism as playing a crucial role in cardiovascu-
lar health has generated significant insights into cardiovascular disease
development and potential new treatments. In order to provide a
forum for the free exchange of ideas by investigators with a special inter-
est in themultiple roles of intermediarymetabolism in the cardiovascular
system, in 2000 the Society for Heart and Vascular Metabolism (SHVM)
was founded. Each year, the SHVM selects a theme for their annualmeet-
ing that focuses on some of the most recent research advances and
emerging areas of importance in cardiovascular metabolism. The 2015
meeting, held in TarrytownN.Y., U.S.A., focused onnovel scientific discov-
eries that provide mechanistic insight into cardiac metabolic dysregula-
tion with an emphasis on translational and post-translational protein
modifications, amino acid metabolism and protein catabolism. Based on
this, a special issue of review articles that highlight the importance of
protein and amino acid metabolism and the role of post-translational
protein modifications on substrate metabolism has been created.
Post-translational protein modifications include phosphorylation,
acetylation, glycation, and O-GlcNAcylation. For phosphorylation, the in-
volvement of the energy sensing kinase, AMP-activated protein kinase
(AMPK), has been reviewed by Jason Dyck and colleagues [1] in the con-
text of how AMPK controls cellular metabolism as well as other aspects
of overall cellular health and survival. As our understanding of the post-
translational regulation of proteins has grown, the involvement of acetyla-
tion is also reviewed. The review by Arata Fukushima and Gary D.
Lopaschuk [2], details the studies demonstrating how acetylation controls
cardiac fatty acid β-oxidation in obesity, diabetes, and heart failure. In ad-
dition, the role of acetylation as a control mechanism for transcriptional
regulation in the healthy and stressed hearts, is reviewed by Ravi
Ramasamy and colleagues [3], providing further evidence of the impor-
tance of acetylation in the control of a wide variety of cellular processes.
Adding to this growing list of post-translational protein modifica-
tions that regulate protein function are both O-linked attachment of
the monosaccharide β-N-acetylglucosamine (O-GlcNAcylation) as well
as glycation, which involves a complex set of pathways that mediates
advanced glycation endproduct (AGE) formation. Luc Bertrand and
colleagues [4] discuss the molecular regulation of protein O-
GlcNAcylation and describe the role of this process in various cardiac
pathologies, whereas Ann Marie Schmidt and colleagues [5] review
the recent work in the field highlighting the roles for AGE formation
in obesity and atherosclerosis and discuss how new approaches may
beused to prevent the adverse consequences of AGEs. Lastly, asmultiple
post-translational processes can regulate the ability of the cardiomyo-
cyte to transport fatty acids into the cell for subsequent energy
production, Joost J Luiken, Jan. F.C. Glatz, and colleagues [6], reviewhttp://dx.doi.org/10.1016/j.bbadis.2016.09.018
0925-4439/© 2016 Elsevier B.V. All rights reserved.the post-translational control of the major protein involved in fatty
acid transport, i.e., CD36, and discuss the importance of this regulation
on cardiomyocyte function in health and disease.
Another area of research of this special issue is related to protein ca-
tabolism and amino acid metabolism. For the former, the importance of
autophagy in the turnover of cellular proteins and how this contributes
to overall cell health has now been established. Based on this, Traci L
Parry and Monte S Willis [7] review the regulation of autophagy by
ubiquitin ligases, review the studies that demonstrate how this cellular
process can alter cardiac metabolism, and discuss how regulating au-
tophagy may be useful as a therapeutic strategy to protect the heart.
For amino acid metabolism, recent evidence has shown that the types
of amino acids used by the heart for energy also influences overall car-
diac function. Indeed, given the emerging data implicating branched
chain amino acid metabolism in a variety of metabolic diseases as well
as heart failure, Yibin Wang and Haipeng Sun [8] review how branched
chain amino acid metabolism is altered in heart failure and the conse-
quences of these alterations heart failure. P. Christian Schulze and
Xiaokan Zhang [9] also review how miRNAs regulate important meta-
bolic pathways in heart failure and discuss the potential benefits of
using miRNAs as therapy for heart disease. Lastly, Merry L. Lindsey
and colleagues [10] discuss how the inflammatory response in involved
inmany forms of cardiac pathologies and the need to better understand
howmacrophages regulate both reparative responses of the left ventri-
cle following myocardial infarction.
Overall, this collection of reviews highlights the importance of cardio-
vascular metabolism in cardiovascular disease and reviews multiple reg-
ulatory circuits that contribute to disease pathogenesis. The focus of this
special issue highlights some of the emerging areas of research that pro-
vide mechanistic insight into cardiac and vascular metabolic dysregula-
tion. It is anticipated that this collection of reviews will provide insight
into new areas of investigation that emphasize the importance of post-
translational protein modifications, amino acid metabolism and protein
catabolism on substrate metabolism and overall cardiovascular health.
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